Monoclonal antibody to TNFalpha in septic shock
- PMID: 9734908
- DOI: 10.1016/S0140-6736(98)26023-5
Monoclonal antibody to TNFalpha in septic shock
Comment on
-
Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group.Lancet. 1998 Mar 28;351(9107):929-33. Lancet. 1998. PMID: 9734938 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
